<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Fakulty</title>
<link href="https://hdl.handle.net/20.500.14178/1" rel="alternate"/>
<subtitle>Faculties</subtitle>
<id>https://hdl.handle.net/20.500.14178/1</id>
<updated>2026-05-05T06:43:36Z</updated>
<dc:date>2026-05-05T06:43:36Z</dc:date>
<entry>
<title>Does Lung Adenocarcinoma Subtyping Offer Clinical Benefits? A Population-Based Study from Sweden</title>
<link href="https://hdl.handle.net/20.500.14178/3796" rel="alternate"/>
<author>
<name>Zitrický, František</name>
</author>
<author>
<name>Sundquist, Kristina</name>
</author>
<author>
<name>Sundquist, Jan</name>
</author>
<author>
<name>Försti, Asta</name>
</author>
<author>
<name>Hemminki, Akseli</name>
</author>
<author>
<name>Kaaks, Rudolf</name>
</author>
<author>
<name>Hemminki, Kari Jussi</name>
</author>
<id>https://hdl.handle.net/20.500.14178/3796</id>
<updated>2026-05-05T06:41:21Z</updated>
<published>2026-01-01T00:00:00Z</published>
<summary type="text">Does Lung Adenocarcinoma Subtyping Offer Clinical Benefits? A Population-Based Study from Sweden
Zitrický, František; Sundquist, Kristina; Sundquist, Jan; Försti, Asta; Hemminki, Akseli; Kaaks, Rudolf; Hemminki, Kari Jussi
Purpose: Classification of lung adenocarcinoma into subtypes is relatively recent and not universally practiced. Consequently, large representative studies describing clinical outcomes are rare, failing to pervasively present advantages of subtyping. We describe the situation in Sweden with focus on survival.Methods: Patient data were obtained from the Swedish cancer registry from 2005 to 2021 accounting for 1418 patients, less than 5% of the reference group 'adenocarcinoma not otherwise specifed (NOS)'. Non-parametric survival estimates were calculated using the Kaplan-Meier method and testing for linear consistency using Weibull modelling.Results: Survival was generally better for women compared to men and this was most prominent for early-stage cancers. Female 5-year survival decreased in order, lepidic (59%), papillary (51%), invasive mucinous (46%), colloid (36%) and adenocarcinoma NOS (24%). Male 5-year survival for lepidic (46%) and colloid subtypes (22%) was significantly lower than female survival. Survival slopes for T1, T2, N0, M0 cases of lepidic, papillary and adenocarcinoma NOS were almost linear, in agreement with Weibull modelling k-values of 1.00 or slightly higher, impling that mortality increased slowly with time.Conclusions: The results showed female survival advantage for all adenocarcinoma subtypes. Survival in T1 and T2 classes with N0 and M0 for lepidic, papillary and adenocarcinoma NOS was close to linear, suggesting that patients are homogeneously diagnosed and treated. Survival benefits of lepidic and papillary subtypes over adenocarcinoma NOS give justification for adenocarcinoma subclassification, and also an independent validation of the WHO 2021 adenocarcinoma grading classification specifying lepidic and papillary subtypes.
</summary>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>RECENT SURVIVAL TRENDS IN THE MOST FATAL CANCERS IN THE NORDIC COUNTRIES: GAINS IN SOME BUT NOT IN ALL</title>
<link href="https://hdl.handle.net/20.500.14178/3795" rel="alternate"/>
<author>
<name>Hemminki, Kari Jussi</name>
</author>
<author>
<name>Zitrický, František</name>
</author>
<author>
<name>Försti, Asta</name>
</author>
<author>
<name>Hemminki, Akseli</name>
</author>
<id>https://hdl.handle.net/20.500.14178/3795</id>
<updated>2026-05-05T01:00:23Z</updated>
<published>2026-01-01T00:00:00Z</published>
<summary type="text">RECENT SURVIVAL TRENDS IN THE MOST FATAL CANCERS IN THE NORDIC COUNTRIES: GAINS IN SOME BUT NOT IN ALL
Hemminki, Kari Jussi; Zitrický, František; Försti, Asta; Hemminki, Akseli
BackgroundGlobal survival studies distinguish a group of solid cancers with especially poor survival, which in the Nordic countries are cancers of the hypopharynx, esophagus, stomach, liver, gallbladder, pancreas, lung and pleura, each with a 5-year overall survival ranging between 15 to 30%. These cancers need extra attention.MethodsWe analyze here 1- and 5- year relative survival in the above cancers in Denmark, Finland, Norway and Sweden comparing periods 2013-18 and 2019-23 using the NORDCAN database.ResultsSurvival improvement was significant for lung cancer in each country, more for women than for men. For females, 1- and 5-year lung cancer survival improvements were about 5 and 6 % units between the two periods, compared to all cancer of 1.5 and 2 % units, respectively. Regarding other individual sites, Norway and Sweden demonstrated significant survival improvements in stomach cancer, and Norway also in pancreatic cancer. However, non-significant survival improvements were observed for most cancers. No positive evidence was found for esophageal cancer in Finland and gallbladder cancer in Norway. More significant improvements were found for 1- than for 5-year survival.ConclusionsSurvival in lung cancer increased in all countries well over improvements for all cancers. Survival increased also significantly for stomach and pancreatic cancers in some countries, and improvements were seen for other cancers. Although the results show success in fight against the most fatal cancers, continuous efforts are needed in early detection, facile clinical handling and novel therapeutics. However, for these fatal cancers primary prevention would be highly rewarding.
</summary>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Three-generation familial risks in prostate cancer with a special focus on the early onset patients and their maternal and paternal relatives</title>
<link href="https://hdl.handle.net/20.500.14178/3794" rel="alternate"/>
<author>
<name>Hemminki, Kari Jussi</name>
</author>
<author>
<name>Zitrický, František</name>
</author>
<author>
<name>Sundquist, Kristina</name>
</author>
<author>
<name>Sundquist, Jan</name>
</author>
<author>
<name>Försti, Asta</name>
</author>
<author>
<name>Hemminki, Akseli</name>
</author>
<author>
<name>Hemminki, Otto</name>
</author>
<id>https://hdl.handle.net/20.500.14178/3794</id>
<updated>2026-05-05T01:00:16Z</updated>
<published>2026-01-01T00:00:00Z</published>
<summary type="text">Three-generation familial risks in prostate cancer with a special focus on the early onset patients and their maternal and paternal relatives
Hemminki, Kari Jussi; Zitrický, František; Sundquist, Kristina; Sundquist, Jan; Försti, Asta; Hemminki, Akseli; Hemminki, Otto
Background: Swedish nationwide family and cancer data extend through three generations providing a unique chance for study of familial cancer in PC between first-degree relatives (FDR) and second-degree relatives (SDR). It also enables a test for the usefulness of maternal family information.Methods: Familial relative risks (standardized incidence ratios, SIRs) for PC were calculated for young men in generation 3 when their brothers, fathers, uncles and grandparents were diagnosed with PC (they were probands).Results: Familial SIRs for two affected brothers were 4.0 but when additionally a SDR (uncle or grandfather) was affected SIR reached 10.3. When a father was the proband, SIR was 3.1 but when additionally a SDR was affected SIR reached 4.7, and risk increased up to 11.6 with increasing numbers of affected SDRs. Importantly, affected SDRs were more numerous than FDRs. When a maternal or paternal grandfather was the only proband SIR for both was about 1.6. Both maternal and paternal uncles transmitted a risk of 1.6, and when two uncles were affected SIR climbed to about 2.0. The highest familial risk of 27 was found for affected brothers with a father and 2 SDRs diagnosed with PC.Conclusions: The results showed that for the young patients in generation 3 the richest sources of familial probands were SDRs. The uncles belong to the generation of fathers, and they are likely to be more numerous than grandparents. Maternal and paternal SDRs are equally informative for genetic counseling and both parental lineages should be used as they provide equal familial information about the risks of PC.
</summary>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>The Concept of Juristic Person</title>
<link href="https://hdl.handle.net/20.500.14178/3793" rel="alternate"/>
<author>
<name>Beran, Karel</name>
</author>
<id>https://hdl.handle.net/20.500.14178/3793</id>
<updated>2026-05-04T01:00:21Z</updated>
<published>2020-01-01T00:00:00Z</published>
<summary type="text">The Concept of Juristic Person
Beran, Karel
The monograph aims to explain the concept of juristic person. It therefore first deals with the question of what it means to be a person under the law and how such a person should be approached in methodological terms. A question follows what the difference is between the concept of a person in civil law and in the Anglo-American (common-law) system. Since a human being and a person are not one and the same concept, the process of getting to know (or studying) a human being cannot be confused with analysing a "person". To learn about a person, one has to analyse the legal order in which the person exists in normative terms, i.e. is valid. Based on analysis of the applicable (positive) law, it can be concluded that a person represents a "point of imputation". If we look at a person as a point of imputation, we will have to face the question of what should be imputed to a person and why. The fact itself that a person represents a point of imputation clarifies in no way whether and why legal personhood should be granted to a juristic person and, on the same note, what legal consequences this will have. Providing an answer to these questions was the objective of various theories of juristic persons, where the most important were the following: the theory of legal fiction; the organic theory; the theory of interest; and the combined theory of juristic persons. These theories are still the subject of discourse, and we need to consider not only their historical significance, but primarily the importance they may carry at the present time. Attempts to provide a theoretical explanation for a juristic person were also closely linked to the views of pure theory of law, as well as postmodern legal concepts. The last group of mutually interconnected issues pertain to the substance of personhood vested in a juristic person, the substance of its legal capacity and the substance of juristic person's liability for a wrong. The answers to all these questions then make it possible to distinguish a juristic person from a mere legal entity, and thus lay down the defining elements of a juristic person.
</summary>
<dc:date>2020-01-01T00:00:00Z</dc:date>
</entry>
</feed>
